Crimean-Congo Hemorrhagic Fever Virus Glycoprotein Processing by the Endoprotease SKI-1/S1P Is Critical for Virus Infectivity
ABSTRACT
Crimean-Congo hemorrhagic fever virus (CCHFV) causes severe human disease. The CCHFV medium RNA encodes a polyprotein which is proteolytically processed to yield the glycoprotein precursors PreGn and PreGc, followed by structural glycoproteins Gn and Gc. Subtilisin kexin isozyme-1/site-1 protease (SKI-1/S1P) plays a central role in Gn processing. Here we show that CCHFV-infected cells deficient in SKI-1/S1P produce no infectious virus, although PreGn and PreGc accumulated normally in the Golgi apparatus, the site of virus assembly. Only nucleoprotein-containing particles which lacked virus glycoproteins (Gn/Gc or PreGn/PreGc) were secreted. Complementation of SKI-1/S1P-deficient cells with a SKI-1/S1P expression vector restored release of infectious virus (>10 6 PFU/ml), confirming that SKI-1/S1P processing is required for incorporation of viral glycoproteins. SKI-1/S1P may represent a promising antiviral target.
Top-30
Journals
|
1
2
3
4
5
6
7
|
|
|
Journal of Virology
7 publications, 8.14%
|
|
|
Viruses
6 publications, 6.98%
|
|
|
Future Virology
4 publications, 4.65%
|
|
|
Antiviral Research
4 publications, 4.65%
|
|
|
PLoS Pathogens
4 publications, 4.65%
|
|
|
Journal of General Virology
3 publications, 3.49%
|
|
|
Archives of Virology
3 publications, 3.49%
|
|
|
Nature Communications
3 publications, 3.49%
|
|
|
Virus Research
3 publications, 3.49%
|
|
|
Journal of Medical Virology
3 publications, 3.49%
|
|
|
International Journal of Peptide Research and Therapeutics
2 publications, 2.33%
|
|
|
Scientific Reports
2 publications, 2.33%
|
|
|
PLoS Neglected Tropical Diseases
2 publications, 2.33%
|
|
|
PLoS ONE
2 publications, 2.33%
|
|
|
npj Vaccines
2 publications, 2.33%
|
|
|
Emerging Infectious Diseases
1 publication, 1.16%
|
|
|
Vector-Borne and Zoonotic Diseases
1 publication, 1.16%
|
|
|
Reviews in Medical Microbiology
1 publication, 1.16%
|
|
|
Frontiers in Immunology
1 publication, 1.16%
|
|
|
Cell Reports
1 publication, 1.16%
|
|
|
Virologica Sinica
1 publication, 1.16%
|
|
|
Cell Host and Microbe
1 publication, 1.16%
|
|
|
Cytokine and Growth Factor Reviews
1 publication, 1.16%
|
|
|
Travel Medicine and Infectious Disease
1 publication, 1.16%
|
|
|
Infection, Genetics and Evolution
1 publication, 1.16%
|
|
|
Virology
1 publication, 1.16%
|
|
|
Biochemical Pharmacology
1 publication, 1.16%
|
|
|
Journal of Biological Chemistry
1 publication, 1.16%
|
|
|
Biochemical and Biophysical Research Communications
1 publication, 1.16%
|
|
|
1
2
3
4
5
6
7
|
Publishers
|
2
4
6
8
10
12
14
16
18
20
|
|
|
Elsevier
19 publications, 22.09%
|
|
|
Springer Nature
15 publications, 17.44%
|
|
|
Public Library of Science (PLoS)
8 publications, 9.3%
|
|
|
American Society for Microbiology
8 publications, 9.3%
|
|
|
MDPI
6 publications, 6.98%
|
|
|
Taylor & Francis
5 publications, 5.81%
|
|
|
Wiley
5 publications, 5.81%
|
|
|
Microbiology Society
3 publications, 3.49%
|
|
|
American Association for the Advancement of Science (AAAS)
3 publications, 3.49%
|
|
|
Frontiers Media S.A.
2 publications, 2.33%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 2.33%
|
|
|
Centers for Disease Control and Prevention (CDC)
1 publication, 1.16%
|
|
|
Mary Ann Liebert
1 publication, 1.16%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 1.16%
|
|
|
American Society for Biochemistry and Molecular Biology
1 publication, 1.16%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.16%
|
|
|
IMR Press
1 publication, 1.16%
|
|
|
2
4
6
8
10
12
14
16
18
20
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.